---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-035596"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T04:30:07.723272+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardelyx reports Q3 net income $6.6M; IBSRELA sales $22.3M; raises FY guidance to $76-78M

## Summary
- Q3 net income $6.6M ($0.03/share) vs net loss $22.9M in Q3 2022; total revenue $56.4M vs $5.0M.
- IBSRELA U.S. net sales $22.3M (22% QoQ growth); FY 2023 guidance raised to $76-78M.
- XPHOZAH FDA approved Oct 17, 2023; commercial launch underway, product in channel early Nov.
- Cash, cash equivalents & short-term investments $165.1M at Sep 30; ~$218.1M as of Oct 30.
- Received $30M milestone from Kyowa Kirin for Japan approval; drew $22.5M from SLR loan amendment.

## SEC filing metadata
- accession: 0001628280-23-035596
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/0001628280-23-035596-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/ardx-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-035596
- JSON: https://secwatch.observer/filing/0001628280-23-035596.json
- Plain text: https://secwatch.observer/filing/0001628280-23-035596.txt

## Key facts
- Earnings Releases
  ARDELYX, INC. updated its the third quarter ended September 30, 2023 guidance (reaffirmed).
  - Period: the third quarter ended September 30, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On October 31, 2023, Ardelyx, Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/0001628280-23-035596-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.